1. Inflammatory myopathies: evaluation and management;SA Greenberg;Semin Neurol,2008
2. Polymyositis, dermatomyositis and inclusion-body myositis;MC Dalakas;N Engl J Med,1991
3. Polymyositis and dermatomyositis (second of two parts);A Bohan;N Engl J Med,1975
4. Validation of manual muscle testing and a subset of eight muscles for adult and juvenile idiopathic inflammatory myopathies;LG Rider;Arthritis Care Res (Hoboken),2010
5. Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), physician global damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index-2 (FI-2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI);LG Rider;Arthritis Care Res (Hoboken),2011